Matthias Schwarz
Matthias Schwarz, Deggingen DE
Patent application number | Description | Published |
---|---|---|
20110029125 | APPARATUS FOR CONTROLLING A MACHINE TOOL - An apparatus on a machine tool for machining workpieces, preferably for machining workpieces by removing material, is provided to control functions of the machine tool and to program and/or test the machining of workpieces and/or to test the machine tool itself. The apparatus is provided with at least one display unit and at least one input unit, whereby masks for displaying and/or for inputting, via the input unit, machine and/or control parameters are displayable on the display unit. A start matrix having a grid of fields, which are stored in a geometrically addressable manner and are preferably arranged in rows and columns, can be displayed on the display unit, the input unit which is separate from the display unit being able to be used to select each field via its geometrical position in the grid at which it is displayed on the display unit, and the assigned function being able to be immediately triggered or a mask being able to be immediately displayed on the display unit by activating a field. | 02-03-2011 |
Matthias Schwarz, Thonex CH
Patent application number | Description | Published |
---|---|---|
20100305092 | TRIAZOLE OXADIAZOLES DERIVATIVES - The invention relates to compounds of formula I: | 12-02-2010 |
20100305137 | PIPERAZINE DERIVATIVES AND METHODS OF USE - The invention provides 2-carboxamide piperazine compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for the treatment of mammalian infertility. | 12-02-2010 |
20130143893 | PIPERAZINE DERIVATIVES AND METHODS OF USE - The invention provides 2-carboxamide piperazine compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for the treatment of mammalian infertility. | 06-06-2013 |
Matthias Schwarz, Gland CH
Patent application number | Description | Published |
---|---|---|
20090054447 | 2,3 Substituted Pyrazine Sulfonamides as Inhibitors of CRTH2 - The present invention is related to the use of 2,3 substituted pyrazine sulfonamides of formula (I) for the treatment and/or prevention of allergic diseases, inflammatory dermatoses and other diseases with an inflammatory component. Specifically, the present invention is related to the use of 2,3 substituted pyrazine sulfonamides for the modulation, notably the inhibition, of CRTH2 activity. | 02-26-2009 |
20090318486 | Tricyclic spiro derivatives as CRTH2 modulators - The present invention is related to the use of spiro derivatives of Formula (I) for the treatment and/or prevention of allergic diseases, inflammatory dermatoses and other diseases with an inflammatory component. Specifically, the present invention is related to the use of spiro derivatives for the modulation of CRTH2 activity. | 12-24-2009 |
20100210619 | 6-Amino-Pyrimidine-4-Carboxamide Derivatives and Related Compounds Which Bind to the Sphingosine 1-Phosphate (S1P) Receptor for the Treatment of Multiple Sclerosis - The invention relates to compounds of formula (I): | 08-19-2010 |
20120028959 | DIHYDROOROTATE DEHYDROGENASE INHIBITORS - The invention relates to compounds of formula (I) wherein R | 02-02-2012 |
20120295889 | 3-Arylamino Pyridine Derivatives - The invention provides novel, substituted 3-arylamino pyridine compounds | 11-22-2012 |
20130109669 | 6-AMINO-PYRIMIDINE-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS WHICH BIND TO THE SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR FOR THE TREATMENT OF MULTIPLE SCLEROSIS | 05-02-2013 |
Matthias Schwarz, Flieden DE
Patent application number | Description | Published |
---|---|---|
20100174116 | Activated Base Metal Catalysts - Nitro-compounds are hydrogenated with an activated Ni catalyst that is doped during and/or after activation with one or more elements from the list of Mg, Ca, Ba, Ti, Zr, Ce, Nb, Cr, Mo, W, Mn, Re, Fe, Co, Ir, Ni, Cu, Ag, Au, Rh, Ru and Bi whereas the Ni/Al alloy may not, but preferentially can contain prior to activation one or more doping elements from the list of Ti, Ce, V, Cr, Mo, W, Mn, Re, Fe, Ru, Co, Rh, Ir, Pd, Pt and Bi. If the Ni/Al alloy contained one or more of the above mentioned suitable alloy doping elements prior to activation, the resulting catalyst can then be doped with one or more of the elements from the list of Mg, Ca, Ba, Ti, Zr, Ce, V, Nb, Cr, Mo, W, Mn, Re, Fe, Ru, Co, Rh, Ir, Ni, Pd, Pt, Cu, Ag, Au and Bi by their adsorption onto the surface of the catalyst. | 07-08-2010 |
20100185026 | Activated Base Metal Catalysts - Nitro-compounds are hydrogenated with an activated Ni catalyst whose Ni/Al alloy also contained one or more elements from the list of Cu, Ag and Au prior to activation. In combination with the Group IB elements mentioned above, this catalyst can also be doped with other elements via their addition to the Ni/Al alloy prior to activation and/or they can be adsorbed onto the surface of the catalyst either during or after the activation of the alloy. The suitable doping elements for the alloy prior to activation in combination with the group IB elements mentioned above are one or more of the elements from the list of Mg, Ti, Ce, Cr, V, Mo, W, Mn, Re, Fe, Co, Tr, Ru, Rh, Pd, Pt and Bi. The suitable doping elements that may be adsorbed onto the surface of the catalyst that was previously doped in the alloy prior to activation with the group IB elements mentioned above are one or more elements from the list Mg, Ca, Ba, Ti, Ce, V, Cr, Mo, W, Mn, Re, Fe, Ru, Co, Rh, Ir, Pd, Pt, Ni, Cu, Ag, Au and Bi. | 07-22-2010 |
20100204517 | Activated Base Metal Catalysts - Nitro-compounds are hydrogenated with an activated Ni catalyst that has an average particle size (APS) less than 25 μm and is doped with one or more elements from the list of Mg, Ce, Ti, V, Nb, Cr, W, Mn, Re, Fe, Ru, Co, Rh, Ir, Pt, Cu, Ag, Au and Bi via its/their addition to the alloy before activation and/or doped with one or more elements from the list of Mg, Ce, Ti, V, Nb, Cr, W, Mn, Re, Fe, Ru, Co, Rh, Ir, Ni, Cu, Ag, Au and Bi by their adsorption onto the surface of the activated catalyst. This invention also includes the hydrogenation of nitro-compounds with an activated Ni catalyst that has and APS less than 20 μm and is doped with one or more elements from the list of Mg, Ce, Ti, V, Nb, Cr, W, Mn, Re, Fe, Ru, Co, Rh, Tr, Pt, Pd, Mo, Cu, Ag, Au and Bi via its/their addition to the alloy before activation and/or doped with one or more elements from the list of Mg, Ce, Ti, V, Nb, Cr, W, Mn, Re, Fe, Ru, Co, Rh, Ir, Ni, Cu, Pd, Pt, Mo, Ag, Au and Bi by their adsorption onto the surface of the activated catalyst. | 08-12-2010 |
Matthias Schwarz, Mannheim DE
Patent application number | Description | Published |
---|---|---|
20100070331 | ARCHITECTURAL DESIGN FOR SERVICE REQUEST AND ORDER MANAGEMENT APPLICATION SOFTWARE - Methods, systems, and apparatus, including computer program products, for implementing a software architecture design for a software application implementing service request and order management. The application is structured as multiple process components interacting with each other through service interfaces, and multiple service operations, each being implemented for a respective process component. The process components include an Outbound Delivery process component, a Site Logistics Processing process component, an Inventory Processing process component, a Customer Requirement Processing process component, a Supply and Demand Matching process component, a Logistics Execution Control process component, a Service Request Processing process component, a Service Order Processing process component, and a Service Confirmation Processing process component. | 03-18-2010 |
20100070336 | Providing Customer Relationship Management Application as Enterprise Services - Methods and apparatus, including systems and computer program products, for a services architecture design that provides enterprise services having customer relationship management functionality at the level of an enterprise application. The design includes a set of service operations, process components, and optionally deployment units. Suitable business objects are also described. | 03-18-2010 |
20130036115 | GENERIC FRAMEWORK FOR HISTORICAL ANALYSIS OF BUSINESS OBJECTS - The present disclosure describes methods, systems, and computer program products for analyzing historic changes to business objects. One method includes monitoring at least one business object for a modification made to at least one business object node attribute. In response to a monitored modification associated with a particular business object node attribute, a new historical version of the at least one business object node attribute is prepared, the new historical version of the at least one business object node attribute including the modified business object node attribute value. A previous historical version of the at least one business object node attribute is retrieved and updated in response to the monitored modification. The new historical version of the at least one business object node attribute and the updated previous historical version of the at least one business object node attribute are then stored. | 02-07-2013 |
Matthias Schwarz, Geneve CH
Patent application number | Description | Published |
---|---|---|
20080255094 | THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR - The present invention is related to thiazolidine carboxamide derivatives of formula (II) for the treatment and/or prophylaxis of preterm labor, premature birth, dysmenorrhea and for stopping labor prior to cesarean delivery. | 10-16-2008 |
20090093462 | 3-Arylamino pyridine derivatives - The invention provides novel, substituted 3-arylamino pyridine compounds (I) pharmaceutically acceptable salts, solvates and prodrug compounds thereof, wherein W, R1, R2, R9, R10, R11, R12, R13, R14 are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer, restenosis and inflammation. Also disclosed is the use of such compounds in the treatment of hyperproliferative diseases in mammals, especially humans, and pharmaceutical compositions containing such compounds. | 04-09-2009 |
20090215749 | THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR - The present invention is related to thiazolidine carboxamide derivatives of formula (II) for the treatment and/or prophylaxis of preterm labor, premature birth, dysmenorrhea and for stopping labor prior to cesarean delivery. | 08-27-2009 |
20140051686 | 3-Arylamino Pyridine Derivatives - The invention provides novel, substituted 3-arylamino pyridine compounds | 02-20-2014 |
Matthias Schwarz, Geneva CH
Patent application number | Description | Published |
---|---|---|
20090029998 | Thiazole Derivatives and Use Thereof - The present invention is related to thiazole derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries. | 01-29-2009 |
Matthias Schwarz, Gland (vd) CH
Patent application number | Description | Published |
---|---|---|
20080287474 | Antiproliferative Pyrimidyl, Fused Pyrimidyl and Pyrimidyl Hydrazones - The present invention is related to a novel series of pyrimidyl or fused pyrimidyl hydrazones. Compounds of Formula (I) wherein A is selected from the group consisting of Formulas (A1), (A2), (A3), (A4), (A5) are useful for the treatment and/or prevention of a proliferative disease. | 11-20-2008 |
20120238575 | ANTIPROLIFERATIVE PYRIMIDYL, FUSED PYRIMIDYL AND PYRIMIDYL HYDRAZONES - The present invention is related to a novel series of pyrimidyl or fused pyrimidyl hydrazones. Compounds of Formula (I) wherein A is selected from the group consisting of Formulas (A1), (A2), (A3), (A4), (A5) are useful for the treatment and/or prevention of a proliferative disease. | 09-20-2012 |
Matthias Schwarz, Glard CH
Patent application number | Description | Published |
---|---|---|
20110224192 | 3-Arylamino Pyridine Derivatives - The invention provides novel, substituted 3-arylamino pyridine compounds | 09-15-2011 |
Matthias Schwarz, Walldorf DE
Patent application number | Description | Published |
---|---|---|
20130238657 | Optimizing Software Applications - Techniques for optimizing a software application include receiving, at a local computing system, a query from an application for data stored on a database table, the query including a context defined by a name of the database table; comparing the context of the query to a context of a predefined query scenario; based on the context of the query matching the context of the predefined query scenario, retrieving data stored on a secondary database replicated from data stored on a main database; and passing the retrieved data from the secondary database to the application. | 09-12-2013 |
Matthias Schwarz, Paderborn DE
Patent application number | Description | Published |
---|---|---|
20130338801 | METHOD AND CONFIGURATION ENVIRONMENT FOR SUPPORTING THE CONFIGURATION OF AN INTERFACE BETWEEN SIMULATION HARDWARE AND AN EXTERNAL DEVICE - A method for supporting a configuration of an interface is provided, wherein the configuration environment has an overview region that has several subregions. At least one item of information concerning a part of the configuration is displayed in each subregion. For each subregion, an item of information concerning the part of the configuration associated with the subregion is displayed. In the case of a warning and/or error message, a configuration option is displayed so as to be selectable, via which the warning/error message is resolved. The selection of the displayed configuration option causes a functionality to be started via which the displayed configuration option is made possible. In the case of a change in the status of a subregion, the display of the status and/or warning and/or error message and a configuration option derived therefrom in one subregion or several subregions is automatically updated and adapted to the changed status. | 12-19-2013 |